Evaxion announces positive data for lead antigens in cytomegalovirus (CMV) vaccine program EVX-V1

Evaxion’s AI-Immunology™ platform has discovered novel CMV antigens that significantly reduce viral infection in preclinical models EVX-V1 is a ...
Townsville Bulletin

Hidden pregnancy virus: Why experts want all parents to know about CMV

Looking at him now, our blue-eyed, funny, fearless little boy, Tom, it was all worth it. Every what if, every tear shed, every moment of doubt my husband, Liam, and I had since March 3, 2023, the day ...
News Medical

Novel vaccine approach appears to protect fetus from CMV infection, animal study shows

Long before the Zika virus became a global fear, cytomegalovirus, or CMV, was commonly infecting developing fetuses and causing many of the same brain and developmental impairments. The virus, one of ...
JSTOR Daily

Prevalence of Congenital Cytomegalovirus Infection and Associated Risk of In Utero Human Immunodeficiency Virus (HIV) Acquisition in a High-HIV Prevalence Setting, South Africa

Background. There is a paucity of data on the burden of congenital cytomegalovirus (cCMV) infections in low- and middle-income countries, including their association with maternal human ...
Science Daily

This virus infects millions—and we just discovered its secret weapon

Scientists have discovered a stealthy mechanism that cytomegalovirus (CMV)—the leading infectious cause of birth defects in the U.S.—uses to infiltrate blood vessel cells while evading immune ...
Morningstar

Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint

CAMBRIDGE, MA / ACCESS Newswire / October 22, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced topline results from a Phase 3 pivotal trial evaluating the efficacy of mRNA-1647, the Company's ...